) [153]. This technique is currently not scalable since it relies on pricey startup substrates which can be used to generate psilocybin in less expensive chemical synthesis methodologies. A methodology for de novo manufacture of psilocybin and tryptamine derivatives in Saccharomyces cerevisiae, As a result of the elevated need for https://ralphx111sgu8.hyperionwiki.com/user